Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
מצבים רפואיים
Early-stage Breast Cancer · Hormone Receptor Positive Breast Carcinoma · Invasive Breast Cancer · Stage II Breast Cancer · Stage IIA Breast Cancer · Stage IIB Breast Cancer · Stage III Breast Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
St. Joseph Heritage Healthcare, Fullerton, California, United States
Contact: Principal Investigator (William E. Lawler, M.D.)Cancer Blood and Specialty Clinic, Los Alamitos, California, United States
Contact: Principal Investigator (Vu Phan, M.D.)UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Nicholas P McAndrew, M.D.)Torrance Memorial Physician Network / Cancer Care, Torrance, California, United States
Contact: Principal Investigator (David Chan, M.D.)PIH Health, Whittier, California, United States
Contact: Principal Investigator (Lisa Shing-E Lu Wang, M.D.)Orlando Health, Inc. d/b/a Orlando Health UF Health Center, Orlando, Florida, United States
Ft. Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, United States
Cancer Center of Kansas, Wichita, Kansas, United States
Contact: Principal Investigator (Shaker Dakhil, M.D.)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Laura M Spring, M.D.)
מובילי המחקר
Nicholas P McAndrew, MD
Principal Investigator
UCLA / Jonsson Comprehensive Cancer Center